0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lisinopril Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-39S8092
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Lisinopril Market Insights Forecast to 2028
BUY CHAPTERS

Global Lisinopril Market Research Report 2025

Code: QYRE-Auto-39S8092
Report
July 2025
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lisinopril Market Size

The global market for Lisinopril was valued at US$ 2021 million in the year 2024 and is projected to reach a revised size of US$ 2905 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Lisinopril Market

Lisinopril Market

Lisinopril is typically used for the treatment of high blood pressure, congestive heart failure, acute myocardial infarction (heart attack), and diabetic nephropathy
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lisinopril, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lisinopril.
The Lisinopril market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lisinopril market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lisinopril manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lisinopril Market Report

Report Metric Details
Report Name Lisinopril Market
Accounted market size in year US$ 2021 million
Forecasted market size in 2031 US$ 2905 million
CAGR 5.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 2.5mg
  • 5mg
  • 10mg
  • 20mg
  • 30mg
  • 40mg
Segment by Application
  • Hospital
  • Drug Store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, Lek Pharmaceuticals, Lupin, Mylan Pharmaceuticals, Ranbaxy Pharmaceuticals, Novartis, Teva Pharmaceuticals, Vintage Pharmaceuticals, Watson Laboratories, West Ward Pharmaceutical, Wockhardt, Merck Research Laboratories, Astrazeneca, Alvogen, Hikma, Prinston, Accord Hlthcare, CASI Pharms, Invagen Pharms, SUN Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lisinopril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lisinopril in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Lisinopril Market growing?

Ans: The Lisinopril Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Lisinopril Market size in 2031?

Ans: The Lisinopril Market size in 2031 will be US$ 2905 million.

Who are the main players in the Lisinopril Market report?

Ans: The main players in the Lisinopril Market are Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, Lek Pharmaceuticals, Lupin, Mylan Pharmaceuticals, Ranbaxy Pharmaceuticals, Novartis, Teva Pharmaceuticals, Vintage Pharmaceuticals, Watson Laboratories, West Ward Pharmaceutical, Wockhardt, Merck Research Laboratories, Astrazeneca, Alvogen, Hikma, Prinston, Accord Hlthcare, CASI Pharms, Invagen Pharms, SUN Pharm

What are the Application segmentation covered in the Lisinopril Market report?

Ans: The Applications covered in the Lisinopril Market report are Hospital, Drug Store

What are the Type segmentation covered in the Lisinopril Market report?

Ans: The Types covered in the Lisinopril Market report are 2.5mg, 5mg, 10mg, 20mg, 30mg, 40mg

Recommended Reports

API & Drug Markets

Cardiology & Vascular

Women’s Health Drugs

1 Lisinopril Market Overview
1.1 Product Definition
1.2 Lisinopril by Type
1.2.1 Global Lisinopril Market Value Comparison by Type (2024 VS 2031)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Lisinopril by Application
1.3.1 Global Lisinopril Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Lisinopril Market Size Estimates and Forecasts
1.4.1 Global Lisinopril Revenue 2020-2031
1.4.2 Global Lisinopril Sales 2020-2031
1.4.3 Global Lisinopril Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lisinopril Market Competition by Manufacturers
2.1 Global Lisinopril Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lisinopril Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lisinopril Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lisinopril, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lisinopril, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lisinopril, Product Type & Application
2.7 Global Key Manufacturers of Lisinopril, Date of Enter into This Industry
2.8 Global Lisinopril Market Competitive Situation and Trends
2.8.1 Global Lisinopril Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lisinopril Players Market Share by Revenue
2.8.3 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lisinopril Market Scenario by Region
3.1 Global Lisinopril Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lisinopril Sales by Region: 2020-2031
3.2.1 Global Lisinopril Sales by Region: 2020-2025
3.2.2 Global Lisinopril Sales by Region: 2026-2031
3.3 Global Lisinopril Revenue by Region: 2020-2031
3.3.1 Global Lisinopril Revenue by Region: 2020-2025
3.3.2 Global Lisinopril Revenue by Region: 2026-2031
3.4 North America Lisinopril Market Facts & Figures by Country
3.4.1 North America Lisinopril Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lisinopril Sales by Country (2020-2031)
3.4.3 North America Lisinopril Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lisinopril Market Facts & Figures by Country
3.5.1 Europe Lisinopril Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lisinopril Sales by Country (2020-2031)
3.5.3 Europe Lisinopril Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lisinopril Market Facts & Figures by Region
3.6.1 Asia Pacific Lisinopril Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lisinopril Sales by Region (2020-2031)
3.6.3 Asia Pacific Lisinopril Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lisinopril Market Facts & Figures by Country
3.7.1 Latin America Lisinopril Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lisinopril Sales by Country (2020-2031)
3.7.3 Latin America Lisinopril Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lisinopril Market Facts & Figures by Country
3.8.1 Middle East and Africa Lisinopril Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lisinopril Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lisinopril Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lisinopril Sales by Type (2020-2031)
4.1.1 Global Lisinopril Sales by Type (2020-2025)
4.1.2 Global Lisinopril Sales by Type (2026-2031)
4.1.3 Global Lisinopril Sales Market Share by Type (2020-2031)
4.2 Global Lisinopril Revenue by Type (2020-2031)
4.2.1 Global Lisinopril Revenue by Type (2020-2025)
4.2.2 Global Lisinopril Revenue by Type (2026-2031)
4.2.3 Global Lisinopril Revenue Market Share by Type (2020-2031)
4.3 Global Lisinopril Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lisinopril Sales by Application (2020-2031)
5.1.1 Global Lisinopril Sales by Application (2020-2025)
5.1.2 Global Lisinopril Sales by Application (2026-2031)
5.1.3 Global Lisinopril Sales Market Share by Application (2020-2031)
5.2 Global Lisinopril Revenue by Application (2020-2031)
5.2.1 Global Lisinopril Revenue by Application (2020-2025)
5.2.2 Global Lisinopril Revenue by Application (2026-2031)
5.2.3 Global Lisinopril Revenue Market Share by Application (2020-2031)
5.3 Global Lisinopril Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Actavis Elizabeth
6.1.1 Actavis Elizabeth Company Information
6.1.2 Actavis Elizabeth Description and Business Overview
6.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Actavis Elizabeth Lisinopril Product Portfolio
6.1.5 Actavis Elizabeth Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Company Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Apotex Lisinopril Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Company Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma Lisinopril Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Ivax Pharmaceuticals
6.4.1 Ivax Pharmaceuticals Company Information
6.4.2 Ivax Pharmaceuticals Description and Business Overview
6.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ivax Pharmaceuticals Lisinopril Product Portfolio
6.4.5 Ivax Pharmaceuticals Recent Developments/Updates
6.5 Lek Pharmaceuticals
6.5.1 Lek Pharmaceuticals Company Information
6.5.2 Lek Pharmaceuticals Description and Business Overview
6.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lek Pharmaceuticals Lisinopril Product Portfolio
6.5.5 Lek Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Company Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lupin Lisinopril Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Mylan Pharmaceuticals
6.7.1 Mylan Pharmaceuticals Company Information
6.7.2 Mylan Pharmaceuticals Description and Business Overview
6.7.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Pharmaceuticals Lisinopril Product Portfolio
6.7.5 Mylan Pharmaceuticals Recent Developments/Updates
6.8 Ranbaxy Pharmaceuticals
6.8.1 Ranbaxy Pharmaceuticals Company Information
6.8.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ranbaxy Pharmaceuticals Lisinopril Product Portfolio
6.8.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Company Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Novartis Lisinopril Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Teva Pharmaceuticals
6.10.1 Teva Pharmaceuticals Company Information
6.10.2 Teva Pharmaceuticals Description and Business Overview
6.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceuticals Lisinopril Product Portfolio
6.10.5 Teva Pharmaceuticals Recent Developments/Updates
6.11 Vintage Pharmaceuticals
6.11.1 Vintage Pharmaceuticals Company Information
6.11.2 Vintage Pharmaceuticals Description and Business Overview
6.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vintage Pharmaceuticals Lisinopril Product Portfolio
6.11.5 Vintage Pharmaceuticals Recent Developments/Updates
6.12 Watson Laboratories
6.12.1 Watson Laboratories Company Information
6.12.2 Watson Laboratories Description and Business Overview
6.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Watson Laboratories Lisinopril Product Portfolio
6.12.5 Watson Laboratories Recent Developments/Updates
6.13 West Ward Pharmaceutical
6.13.1 West Ward Pharmaceutical Company Information
6.13.2 West Ward Pharmaceutical Description and Business Overview
6.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.13.4 West Ward Pharmaceutical Lisinopril Product Portfolio
6.13.5 West Ward Pharmaceutical Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Company Information
6.14.2 Wockhardt Description and Business Overview
6.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Wockhardt Lisinopril Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Merck Research Laboratories
6.15.1 Merck Research Laboratories Company Information
6.15.2 Merck Research Laboratories Description and Business Overview
6.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Merck Research Laboratories Lisinopril Product Portfolio
6.15.5 Merck Research Laboratories Recent Developments/Updates
6.16 Astrazeneca
6.16.1 Astrazeneca Company Information
6.16.2 Astrazeneca Description and Business Overview
6.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Astrazeneca Lisinopril Product Portfolio
6.16.5 Astrazeneca Recent Developments/Updates
6.17 Alvogen
6.17.1 Alvogen Company Information
6.17.2 Alvogen Description and Business Overview
6.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Alvogen Lisinopril Product Portfolio
6.17.5 Alvogen Recent Developments/Updates
6.18 Hikma
6.18.1 Hikma Company Information
6.18.2 Hikma Description and Business Overview
6.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Hikma Lisinopril Product Portfolio
6.18.5 Hikma Recent Developments/Updates
6.19 Prinston
6.19.1 Prinston Company Information
6.19.2 Prinston Description and Business Overview
6.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Prinston Lisinopril Product Portfolio
6.19.5 Prinston Recent Developments/Updates
6.20 Accord Hlthcare
6.20.1 Accord Hlthcare Company Information
6.20.2 Accord Hlthcare Description and Business Overview
6.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Accord Hlthcare Lisinopril Product Portfolio
6.20.5 Accord Hlthcare Recent Developments/Updates
6.21 CASI Pharms
6.21.1 CASI Pharms Company Information
6.21.2 CASI Pharms Description and Business Overview
6.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.21.4 CASI Pharms Lisinopril Product Portfolio
6.21.5 CASI Pharms Recent Developments/Updates
6.22 Invagen Pharms
6.22.1 Invagen Pharms Company Information
6.22.2 Invagen Pharms Description and Business Overview
6.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Invagen Pharms Lisinopril Product Portfolio
6.22.5 Invagen Pharms Recent Developments/Updates
6.23 SUN Pharm
6.23.1 SUN Pharm Company Information
6.23.2 SUN Pharm Description and Business Overview
6.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2020-2025)
6.23.4 SUN Pharm Lisinopril Product Portfolio
6.23.5 SUN Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lisinopril Industry Chain Analysis
7.2 Lisinopril Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lisinopril Production Mode & Process Analysis
7.4 Lisinopril Sales and Marketing
7.4.1 Lisinopril Sales Channels
7.4.2 Lisinopril Distributors
7.5 Lisinopril Customer Analysis
8 Lisinopril Market Dynamics
8.1 Lisinopril Industry Trends
8.2 Lisinopril Market Drivers
8.3 Lisinopril Market Challenges
8.4 Lisinopril Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lisinopril Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lisinopril Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lisinopril Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lisinopril Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Lisinopril Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lisinopril Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lisinopril Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lisinopril Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lisinopril, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lisinopril, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lisinopril, Product Type & Application
 Table 12. Global Key Manufacturers of Lisinopril, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lisinopril by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisinopril as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lisinopril Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lisinopril Sales by Region (2020-2025) & (K Units)
 Table 18. Global Lisinopril Sales Market Share by Region (2020-2025)
 Table 19. Global Lisinopril Sales by Region (2026-2031) & (K Units)
 Table 20. Global Lisinopril Sales Market Share by Region (2026-2031)
 Table 21. Global Lisinopril Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lisinopril Revenue Market Share by Region (2020-2025)
 Table 23. Global Lisinopril Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lisinopril Revenue Market Share by Region (2026-2031)
 Table 25. North America Lisinopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lisinopril Sales by Country (2020-2025) & (K Units)
 Table 27. North America Lisinopril Sales by Country (2026-2031) & (K Units)
 Table 28. North America Lisinopril Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lisinopril Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lisinopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lisinopril Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Lisinopril Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Lisinopril Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lisinopril Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lisinopril Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lisinopril Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Lisinopril Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Lisinopril Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lisinopril Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lisinopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lisinopril Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Lisinopril Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Lisinopril Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lisinopril Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lisinopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lisinopril Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Lisinopril Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Lisinopril Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lisinopril Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lisinopril Sales (K Units) by Type (2020-2025)
 Table 51. Global Lisinopril Sales (K Units) by Type (2026-2031)
 Table 52. Global Lisinopril Sales Market Share by Type (2020-2025)
 Table 53. Global Lisinopril Sales Market Share by Type (2026-2031)
 Table 54. Global Lisinopril Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lisinopril Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lisinopril Revenue Market Share by Type (2020-2025)
 Table 57. Global Lisinopril Revenue Market Share by Type (2026-2031)
 Table 58. Global Lisinopril Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Lisinopril Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Lisinopril Sales (K Units) by Application (2020-2025)
 Table 61. Global Lisinopril Sales (K Units) by Application (2026-2031)
 Table 62. Global Lisinopril Sales Market Share by Application (2020-2025)
 Table 63. Global Lisinopril Sales Market Share by Application (2026-2031)
 Table 64. Global Lisinopril Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lisinopril Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lisinopril Revenue Market Share by Application (2020-2025)
 Table 67. Global Lisinopril Revenue Market Share by Application (2026-2031)
 Table 68. Global Lisinopril Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Lisinopril Price (US$/Unit) by Application (2026-2031)
 Table 70. Actavis Elizabeth Company Information
 Table 71. Actavis Elizabeth Description and Business Overview
 Table 72. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Actavis Elizabeth Lisinopril Product
 Table 74. Actavis Elizabeth Recent Developments/Updates
 Table 75. Apotex Company Information
 Table 76. Apotex Description and Business Overview
 Table 77. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Apotex Lisinopril Product
 Table 79. Apotex Recent Developments/Updates
 Table 80. Aurobindo Pharma Company Information
 Table 81. Aurobindo Pharma Description and Business Overview
 Table 82. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Aurobindo Pharma Lisinopril Product
 Table 84. Aurobindo Pharma Recent Developments/Updates
 Table 85. Ivax Pharmaceuticals Company Information
 Table 86. Ivax Pharmaceuticals Description and Business Overview
 Table 87. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ivax Pharmaceuticals Lisinopril Product
 Table 89. Ivax Pharmaceuticals Recent Developments/Updates
 Table 90. Lek Pharmaceuticals Company Information
 Table 91. Lek Pharmaceuticals Description and Business Overview
 Table 92. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Lek Pharmaceuticals Lisinopril Product
 Table 94. Lek Pharmaceuticals Recent Developments/Updates
 Table 95. Lupin Company Information
 Table 96. Lupin Description and Business Overview
 Table 97. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lupin Lisinopril Product
 Table 99. Lupin Recent Developments/Updates
 Table 100. Mylan Pharmaceuticals Company Information
 Table 101. Mylan Pharmaceuticals Description and Business Overview
 Table 102. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Pharmaceuticals Lisinopril Product
 Table 104. Mylan Pharmaceuticals Recent Developments/Updates
 Table 105. Ranbaxy Pharmaceuticals Company Information
 Table 106. Ranbaxy Pharmaceuticals Description and Business Overview
 Table 107. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Ranbaxy Pharmaceuticals Lisinopril Product
 Table 109. Ranbaxy Pharmaceuticals Recent Developments/Updates
 Table 110. Novartis Company Information
 Table 111. Novartis Description and Business Overview
 Table 112. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Novartis Lisinopril Product
 Table 114. Novartis Recent Developments/Updates
 Table 115. Teva Pharmaceuticals Company Information
 Table 116. Teva Pharmaceuticals Description and Business Overview
 Table 117. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceuticals Lisinopril Product
 Table 119. Teva Pharmaceuticals Recent Developments/Updates
 Table 120. Vintage Pharmaceuticals Company Information
 Table 121. Vintage Pharmaceuticals Description and Business Overview
 Table 122. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Vintage Pharmaceuticals Lisinopril Product
 Table 124. Vintage Pharmaceuticals Recent Developments/Updates
 Table 125. Watson Laboratories Company Information
 Table 126. Watson Laboratories Description and Business Overview
 Table 127. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Watson Laboratories Lisinopril Product
 Table 129. Watson Laboratories Recent Developments/Updates
 Table 130. West Ward Pharmaceutical Company Information
 Table 131. West Ward Pharmaceutical Description and Business Overview
 Table 132. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. West Ward Pharmaceutical Lisinopril Product
 Table 134. West Ward Pharmaceutical Recent Developments/Updates
 Table 135. Wockhardt Company Information
 Table 136. Wockhardt Description and Business Overview
 Table 137. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Wockhardt Lisinopril Product
 Table 139. Wockhardt Recent Developments/Updates
 Table 140. Merck Research Laboratories Company Information
 Table 141. Merck Research Laboratories Description and Business Overview
 Table 142. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Merck Research Laboratories Lisinopril Product
 Table 144. Merck Research Laboratories Recent Developments/Updates
 Table 145. Astrazeneca Company Information
 Table 146. Astrazeneca Description and Business Overview
 Table 147. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Astrazeneca Lisinopril Product
 Table 149. Astrazeneca Recent Developments/Updates
 Table 150. Alvogen Company Information
 Table 151. Alvogen Description and Business Overview
 Table 152. Alvogen Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Alvogen Lisinopril Product
 Table 154. Alvogen Recent Developments/Updates
 Table 155. Hikma Company Information
 Table 156. Hikma Description and Business Overview
 Table 157. Hikma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Hikma Lisinopril Product
 Table 159. Hikma Recent Developments/Updates
 Table 160. Prinston Company Information
 Table 161. Prinston Description and Business Overview
 Table 162. Prinston Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Prinston Lisinopril Product
 Table 164. Prinston Recent Developments/Updates
 Table 165. Accord Hlthcare Company Information
 Table 166. Accord Hlthcare Description and Business Overview
 Table 167. Accord Hlthcare Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Accord Hlthcare Lisinopril Product
 Table 169. Accord Hlthcare Recent Developments/Updates
 Table 170. CASI Pharms Company Information
 Table 171. CASI Pharms Description and Business Overview
 Table 172. CASI Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. CASI Pharms Lisinopril Product
 Table 174. CASI Pharms Recent Developments/Updates
 Table 175. Invagen Pharms Company Information
 Table 176. Invagen Pharms Description and Business Overview
 Table 177. Invagen Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Invagen Pharms Lisinopril Product
 Table 179. Invagen Pharms Recent Developments/Updates
 Table 180. SUN Pharm Company Information
 Table 181. SUN Pharm Description and Business Overview
 Table 182. SUN Pharm Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. SUN Pharm Lisinopril Product
 Table 184. SUN Pharm Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Lisinopril Distributors List
 Table 188. Lisinopril Customers List
 Table 189. Lisinopril Market Trends
 Table 190. Lisinopril Market Drivers
 Table 191. Lisinopril Market Challenges
 Table 192. Lisinopril Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lisinopril
 Figure 2. Global Lisinopril Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lisinopril Market Share by Type: 2024 & 2031
 Figure 4. 2.5mg Product Picture
 Figure 5. 5mg Product Picture
 Figure 6. 10mg Product Picture
 Figure 7. 20mg Product Picture
 Figure 8. 30mg Product Picture
 Figure 9. 40mg Product Picture
 Figure 10. Global Lisinopril Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Lisinopril Market Share by Application: 2024 & 2031
 Figure 12. Hospital
 Figure 13. Drug Store
 Figure 14. Global Lisinopril Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Lisinopril Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Lisinopril Sales (2020-2031) & (K Units)
 Figure 17. Global Lisinopril Average Price (US$/Unit) & (2020-2031)
 Figure 18. Lisinopril Report Years Considered
 Figure 19. Lisinopril Sales Share by Manufacturers in 2024
 Figure 20. Global Lisinopril Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Lisinopril Players: Market Share by Revenue in Lisinopril in 2024
 Figure 22. Lisinopril Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Lisinopril Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Lisinopril Sales Market Share by Country (2020-2031)
 Figure 25. North America Lisinopril Revenue Market Share by Country (2020-2031)
 Figure 26. United States Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Lisinopril Sales Market Share by Country (2020-2031)
 Figure 29. Europe Lisinopril Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Lisinopril Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Lisinopril Revenue Market Share by Region (2020-2031)
 Figure 37. China Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Lisinopril Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Lisinopril Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Lisinopril Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Lisinopril Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Lisinopril Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Lisinopril by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Lisinopril by Type (2020-2031)
 Figure 58. Global Lisinopril Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Lisinopril by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Lisinopril by Application (2020-2031)
 Figure 61. Global Lisinopril Price (US$/Unit) by Application (2020-2031)
 Figure 62. Lisinopril Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS